Skip to Main Content

Paper Details

Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients.
Actas Urol Esp (Engl Ed)
0
2021
Author NameAffiliation
Alberto BrigantiUniversita Vita-Salute
N??ria MalatsSpanish National Cancer Research Centre (CNIO).
Robert Jeffrey KarnesMayo Clinic
  • 1 - 3

Datasets

Release 1.2